¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×Ü°æÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ DcRoW  
|'}r-}  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© {J)gS  
o@$py U8  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© w?fq%-6f*  
ze8MFz'm  
1.Co-stimulators (or co-stimulating molecules) AKLFUk  
c.-dwz  
2.NK-kB KCa @0  
%,8 "cM`D  
3.Immunoglobulin superfamily Lrt~Q:z2u  
(L1O;~$  
4.antigen-presenting cell (APC) =td(}3|D Y  
? R[GSS1  
5.death domain PEtr8J$uB  
<pT1p4T<  
6.CCR and CXCR SrWmV@"y  
1TN+pmc}@  
7.Lectin (or mitogen) oB!-JX9  
l@<Jp *|  
8.Clusters of differentiation, CD) FSZ :}Q  
~ ^~+p  
9.B7 family W\ARCcTQ  
kQ6YQsJ.*  
10.Cytotoxic T lymphocyte, CTL) ]>(pQD  
,{RWs^W2  
11.IL-15 and IL-15 receptor (IL-15R) RL"hAUs_1  
,UT :wpc^i  
12.MHC restriction gl n X C  
C !Lu`y  
13.Affinity-chromatography "? 5@j/ e`  
=~$)Ieu  
14.Cyctosprin A, CsA d^aLue>g;+  
u9}LvQh_6,  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) C #@5 :$  
/T<,vR  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© sGbk4g  
Zdu8axK:  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 RjHKFB2  
J35[GZ';D  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ IqjH  
;u?H#\J,  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌص㡣 4d @ (>  
Dj{t[z]$k  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© n0@\x=9  
HN L;s5gq  
ÃâÒßѧרҵ£º 8IihG \  
rt!Uix&  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ vM /D7YS:  
I/w=!Ih  
Ïû»¯ÄÚ¿Æ£º UYOR@x #  
 <nT).S>+  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 0%hOB :  
vZ2/>}!Z=  
ѪҺ²¡Ñ§×¨Òµ£º A^hFR Ag4  
w}QU;rl8q  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÍøÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»